Publications
Most Food Labeling Class Actions Remain Stayed While FDA Process Runs ‘Natural’ Course
October 23, 2017
Consumer class actions over the use of the term ‘‘natural’’ on product labels should be stayed in deference to the Food and Drug Administration’s ongoing consideration of regulatory action, Sidley lawyers Amy Lally and Amanda Farfel say. The large number of comments received by the FDA on the topic reflects the complexity of the issues and the need for expert guidance from the agency the authors say.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Arsenal Capital Partners and MaxHealth in Sale of MaxHealth to CenterWellFebruary 17, 2026Sidley Secures Key Early Victory for Pasadena and Rose Bowl Operating Company in UCLA Stadium DisputeFebruary 13, 2026Trend Watch 2026: Hot Topics in California Regulation and LitigationTuesday, February 10, 2026Sidley Secures Preliminary Injunction Against Oregon Packaging EPR LawFebruary 9, 2026Sidley Represents Lead Arranger in US$1 Billion Financing to Navitas and Rockhopper for First-Ever Development of the Falklands Islands Sea Lion FieldFebruary 9, 2026U.S. FTC Signals Renewed Interest in “Click-to-Cancel” RulemakingFebruary 9, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
